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doi:10.1016/j.ejvs.2009.11.036Abstract Objective: This study aims to evaluate the impact of CO2 venography on the plan-
ning and outcome of native arteriovenous fistula (AVF) creation.
Methods: Records of patients who underwent CO2 venography prior to access surgery between
January 2000 and December 2008 were reviewed. CO2 venography was performed selectively
in chronic kidney disease (CKD) in stage IVeV patients without suitable veins on clinical exam-
ination. Findings at surgery were compared to CO2 venography images. Patency of AVFs was
analysed by the KaplaneMeier method. Differences in outcome of maturation were compared
using a c2 test.
Results: A total of 209 CO2 venograms were obtained in 116 patients. In 89 patients (77%), 101
AVFs (21 forearm AVF (21%) and 80 elbow AVF (79%) were created. Surgical findings corre-
sponded with CO2 venography findings in 90% of patients. In 10 cases (10%), access was created
at the elbow despite a patent forearm cephalic vein on CO2 venography (nZ 2) or access was
attempted with a vein which was thought to be unsuitable on CO2 venography (n Z 8). Matu-
ration rate of the latter was 50% (4/8) vs. 88% (80/91) for AVFs created with veins considered
usable (PZ 0.004). The overall maturation rate was 84% with 1-year primary, assisted primary
and secondary patency rates of 63%, 70% and 71%, respectively.
Conclusion: CO2 venography is a useful tool for venous mapping prior to vascular access
surgery, resulting in an overall maturation rate of 84% and good patency rates.
ª 2009 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Preoperative venous mapping is useful to improve the
success of creating haemodialysis native arteriovenous
fistulas (AVF). This technique enables the identification of343782; fax: þ32 16 343765.
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ty for Vascular Surgery. Publishesuitable veins which are impalpable or invisible on physical
examination.1,2 Preoperative ultrasound (US) and/or
venography are the two most commonly used imaging
modalities before haemodialysis vascular access surgery.3,4
US is non-invasive and allows evaluation of both arteries
and veins in the upper limb, but central veins are only
indirectly assessable. Conventional venography with iodined by Elsevier Ltd. All rights reserved.
Preoperative CO2 Venography 341as contrast medium offers direct imaging of both peripheral
and central veins in the upper limb.1
The major disadvantage of conventional venography is
the use of iodinated contrast medium and the potential risk
of contrast-induced nephropathy (CIN), especially in
patients with end-stage renal disease who do not yet
require haemodialysis.1,5 It is also reported that in patients
with advanced chronic kidney disease (CKD stage 4) and
candidates for haemodialysis, an AVF should be created as
soon as possible, preferably at least 6 months before the
anticipated start of haemodialysis treatment to allow
enough time for maturation, or for potential further
interventions that may be required to ensure appropriate
venous access when dialysis is initiated.6,7
A safe alternative for conventional contrast-enhanced
venography is carbon dioxide (CO2) venography, which
demonstrated a specificity of 97% and a sensitivity of 85% in
assessing upper limb vein patency and stenosis in one
series.5
The purpose of this retrospective study was to evaluate
the impact of CO2 venography on the planning and outcome
of haemodialysis AVF creation.
Methods
The local Ethics Committee waived informed consent and
approved this retrospective study.
The medical and radiological records of all patients who
underwent CO2 venography prior to haemodialysis access
surgery between January 2000 and December 2008 were
reviewed. Patients with CKD stage 4 or 5 were referred to
an experienced vascular surgeon (I.F.) when haemodialysis
was considered the preferred renal replacement therapy.
The decision to undertake venography was made by the
vascular surgeon when clinical examination with and
without tourniquet failed to show a vein suitable for
vascular access creation or when central venous stenosis
had to be excluded because of a history of central venous
catheters or because venous collaterals on the chest wall
were found on physical examination. In all patients, the
upper limb arterial system was considered suitable for
vascular access on physical examination (good arterial
pulse, negative Allen’s test and no significant difference in
blood pressure measured in both arms). The decision to
undertake bilateral or unilateral venography was made
based on surgeon and patient preferences, clinical findings
and medical history.
CO2 was chosen as the contrast medium if the patient
had residual renal function and/or recovery of renal func-
tion was expected. Patients already receiving haemodial-
ysis, but with residual kidney function, were also included
in the study. No preoperative duplex US was used at the
time.
Venography technique
After placement of a 21- or 20-gauge intravenous access
needle in a superficial vein at the dorsum of the hand,
0.1 mg of nitroglycerine was injected prior to the injection
of CO2 to obtain venous dilatation and to prevent vaso-
spasm. Digital subtraction angiography (DSA) images fromthe wrist up to the chest were obtained with the patient’s
arm in the anatomical position, when possible. Between
January 2000 and January 2008, DSA was performed in an
interventional suite with a movable C-arm equipped with
an under-table X-ray tube unit and an image intensifier
above the patient (Polystar, Siemens Medical Solutions and
Angiostar, Siemens Medical Solutions, Erlangen, Germany).
From February 2008 on, DSA procedures were performed in
an angiosuite with a flat-panel detector system (Axiom Artis
dTA, Siemens Medical Solutions, Erlangen, Germany). When
possible (i.e., no motion artefacts during DSA), image
stacking post-processing software was used. A tourniquet
was not applied routinely.
CO2 venograms were obtained using either a CO2 injector
(CO2nnect Autoflush set, Angiodynamics, Queensbury, NY,
USA) or a hand-held commercially available 100 ml syringe
connected with a three way stopcock to a CO2-containing
cylinder on one side and to the patient’s venous access
cannula on the other side (CO2 Angioset, Optimed, Ettlin-
gen, Germany). The syringe has adjustable settings in 20 ml
steps.
In case of the CO2 injector, the injection rate was set to
10 ml s1. The injected volume was always 10 ml for the
first injection to accustom the patient to the resulting
sensation. The following injection volumes varied between
10 ml and 30 ml for opacification of the forearm and upper
arm veins and between 30 ml and 50 ml for the central
veins. DSA images with the CO2 syringe were made with an
injected volume of 20 ml for the arm veins and 20 ml or
40 ml for central vein opacification.
Imaging and data analysis
The CO2 venograms were reviewed by one radiologist
(S.H.). Both cephalic and basilic vein in forearm and upper
arm as well as the central veins were evaluated on whether
they could be used in a haemodialysis AVF. A patent
cephalic or basilic vein without stenosis and with a diam-
eter of at least 2 mm in the forearm or upper arm was
considered usable, although the basilic vein in the forearm
was not routinely used as primary vascular access. The
choice of access was made based on the results of the CO2
venography, but in case of several possible choices,
attempts were made to use the non-dominant arm over the
dominant arm and a radiocephalic forearm AVF over an
elbow AVF. When several choices were possible for an
elbow AVF, a brachial artery-median vein AVF was prefer-
ably used over a brachiocephalic AVF and a brachiocephalic
over a brachiobasilic AVF when the choices were equiva-
lent. Central vein stenosis or occlusion precluded an upper
limb usable for haemodialysis access creation.
Definitions
Primary failure was defined as an AVF that was abandoned
without cannulation ever being successful (AVF considered
impossible to cannulate by the haemodialysis nurse,
vascular surgeon and/or nephrologist) or being requiring
further surgical intervention. The standards for reporting
by Sidawy et al.8 were used for the definition of primary,
primary assisted and secondary patency. Primary patency
342 S. Heye et al.was defined as the interval from the time of AVF creation
until any intervention to maintain or re-establish patency,
AVF thrombosis or the time of measurement of patency.
Primary-assisted patency was defined as the time interval
between AVF creation and abandonment or the time of
measurement of patency including intervening (surgical or
endovascular) manipulations to maintain patency. The
definition of secondary patency was the time interval
between access creation until abandonment or the time of
measurement of patency including interventions to restore
patency of thrombosed access. Patency was evaluated by
clinical examination and duplex US.
Statistical analysis
Patency of the AVF created was evaluated using the
KaplaneMeier method. Data analysis was censored for
patients who died with a patent access or underwent renal
transplantation before reaching the follow-up end points of
3 months, 6 months, 1 year, 2 years, 3 years and 4 years
after haemodialysis access creation. Differences in
outcome of maturation were calculated with the use of c2
test. A p-value of 0.05 or less was considered significant.
Analyses have been performed using SAS software, version
9.2 of the SAS System for Windows (SAS Institute Inc., Cary,
NC, USA).
Results
During the study period, CO2 venography prior to vascular
access surgery was performed in 141 patients. Twenty-five
patients were excluded because additional images withTable 1 Demographics.
Total patient number N Z 116 (%)
Gender
M/F 46/70 (39.7/60.3)
Age (y)
Mean 58
Range 2e87
Aetiology CKD stage V
Diabetes mellitus 23 (19.8)
Renal vascular disease 17 (14.7)
Glomerular disease 19 (16.4)
Tubulo-interstitial disease
/obstructive
21 (18.1)
Autosomal dominant
polycystic kidney disease
3 (2.59)
Calcineurin-inhibitor associated
nephrotoxicity
10 (8.6)
Other/unknown 23 (19.8)
Comorbidities
Arterial hypertension 67 (57.8)
Diabetes mellitus 40 (34.5)
Prior AVF 26 (22.4)
Already receiving haemodialysis
Tunneled catheter 12 (10.3)
Non-tunneled catheter 13 (11.2)iodinated contrast were made according to another study
protocol (nZ 22) or because the images were lost (nZ 3),
resulting in 116 patients (46 men, 70 women) available for
analysis (Table 1). Twenty-five patients (22%) were already
undergoing haemodialysis with either a non-tunneled
(n Z 13) or a tunneled haemodialysis catheter (n Z 12).
In 23 patients (20%), CO2 venography of one upper limb
(right/left: 12/11) was performed; the remaining 93
patients (80%) underwent bilateral CO2 venography,
resulting in a total of 209 upper limb CO2 venograms.
Indications for unilateral venography were a failing prior
AVF in either the same (nZ 3) or contralateral (nZ 5) arm,
preference for the non-dominant arm (n Z 5), known
contralateral central vein thrombosis (nZ 2), port catheter
in the contralateral arm (nZ 2), contralateral spasm after
cerebrovascular accident (n Z 1), lymphoedema after
mastectomy and lymphadenectomy (n Z 3) and coronary
artery bypass graft using the left internal mammary artery
(n Z 2). Technical success was 100%. No procedural
complications were seen and injection of CO2 was well
tolerated by all patients.
A central venous stenosis greater than 50% or a central
vein occlusion was present in 15 venograms (7%). More than
50% of the stenoses were located in the subclavian vein
(n Z 8). Central vein occlusion was found either in the
subclavian vein (n Z 2), the innominate vein (n Z 3) or
both subclavian and innominate veins (n Z 2).
Of the 209 CO2 venograms, 57 cephalic veins in the
forearm (27%) in 40 patients (35%) were considered suitable
for access creation, as well as 48 basilic veins in the fore-
arm (23%) in 38 patients (33%). Upper arm veins were more
often seen and considered suitable based on CO2 venog-
raphy: 79 cephalic veins (38%) in 56 patients (48%) and 175
basilic veins (84%) in 106 patients (91%). A mean of 1.7
suitable veins per CO2 venogram (359/209) were found.
Twenty-seven of the 116 patients (23%) did not receive
a native AVF as haemodialysis access. Nine patients (8%)
were considered unsuitable for AVF creation based on the
CO2 venograms. Six of these nine patients (67%) underwent
a haemodialysis AV-graft (AVG) creation (five straight AVGs
in the upper arm and one axillo-femoral AVG), and the
remaining three patients were lost to follow-up. Another
three patients (3%) continued haemodialysis through
a tunneled cuffed catheter. Eight patients (7%) did not
require vascular access in the end, because of partial renal
function recovery or a stabilisation of renal function. Two
patients had renal transplantation during the interval
between CO2 venography and planned vascular access
surgery. Four patients (4%) eventually went on to peritoneal
dialysis instead of haemodialysis and one patient refused
access surgery.
In the remaining 89 patients (77%), a native AVF was
created. Twelve of them (14%) received a second AVF based
on the existing CO2 venography, resulting in a total of 101
AVFs of which 21 forearm AVFs (21%) and 80 elbow AVFs
(79%) are summarised in Table 2. In nine of the latter 12
patients, a new access was created because of non-matu-
ration. The remaining three patients had a matured AVF
that thrombosed after a mean of 180 days (range: 50e335
days). One of them had already undergone haemodialysis
through this AVF before thrombosis; the other two were not
yet haemodialysis dependent.
Table 2 Native AVF creation.
Total AVF number N Z 101 (%)
Forearm
Radiocephalic 20 (19.8)
Ulnobasilic 1 (0.99)
Upper arm
Brachial artery e median cubital vein 22 (21.8)
Brachiocephalic 33 (32.7)
Non-transposed brachiobasilic 14 (13.9)
Transposed brachiobasilic 11 (10.9)
Table 3 (A) Primary, assisted primary (B) and secondary
(C) patency of the created AVF.
Patency (mo) Survival Lower limit
of 95%CI
Upper limit
of 95%CI
A. Primary patency
1 86 77 91
3 78 68 85
6 71 60 79
10 64 53 73
12 63 52 72
24 50 39 60
36 44 32 55
48 40 28 52
B. Assisted primary patency
1 86 77 92
3 79 69 86
6 74 64 82
10 71 60 79
12 70 59 78
24 61 49 70
36 59 47 69
48 55 42 67
C. Secondary patency
1 86 77 92
3 79 69 86
6 76 65 83
10 72 61 80
12 71 60 79
24 62 50 72
36 60 48 70
48 56 43 68
Preoperative CO2 Venography 343Vascular access surgery corresponded with the findings
of CO2 venography in 90% of cases (91/101). In the
remaining 10 cases, vascular access was created at the
elbow although a patent cephalic vein in the forearm was
seen on CO2 venography (n Z 2) or access creation was
attempted with a vein that was considered not suitable on
CO2 venography (n Z 8). The maturation rate of the latter
eight AVFs was 50% (4/8) vs. 88% (80/91) for the AVF
created with veins considered suitable for access surgery on
CO2 venography (P Z 0.004).
Ten patients were lost to follow-up after access creation
because of further therapy in other dialysis units. In total,
primary failure or non-maturation of the AVF was seen in 15
of the 91 AVFs created (17%). This occurred in seven radi-
ocephalic AVFs (35% of all radiocephalic AVFs), one ulno-
basilic AVF (100%), four brachiocephalic AVFs (12.1%), two
brachiobasilic AVFs (8%) and one brachial artery-median
vein fistula.
One-year primary, assisted primary and secondary
patency rates for the 91 AVFs were calculated and was 63%
(95% confidence interval (CI): 52%; 72%), 70% (95% CI: 59%;
78%) and 71% (95% CI: 60%; 79%), respectively (Table 3, Figs.
1e3).
Eighteen of the 26 patients with previous native hae-
modialysis fistulas (69%) received an AVF after CO2 venog-
raphy. Ten of them (39%) had had one AVF in the past and
eight (31%) had had two previous AVFs. One patient was lost
to follow-up; of the remaining 17 patients, non-maturation
occurred in three patients (18%). Maturation rates between
patients with a prior AVF and patients with a first-access
AVF were not significantly different (82% vs. 84% respec-
tively, N.S.).
Discussion
Venography and venous US are commonly used imaging
modalities for preoperative venous mapping to increase
the prevalence of a native AVF as haemodialysis
access.2,4 Although the risk for CIN after conventional
venography in patients with end-stage renal disease
appears to be lower than initially thought if low doses of
iodinated contrast material are used,4,9,10 CO2 venog-
raphy was shown to be a safe alternative in one series.5
This was confirmed in our series, where technical success
was 100%, without complication, although potential bias
could not be excluded given the retrospective nature of
the study.In our series, preoperative venous mapping by CO2
venography in patients without suitable veins on physical
examination resulted in AVF access creation in 77% of
patients. This is comparable to the study of Patel et al.
where venography or a combination of venography and US
was used.11 However, this figure is lower than results
reported in the study of Huber et al. where a native AVF
was created in 90% of patients who underwent both US and
invasive preoperative imaging following an algorithm.12
Hyland et al. reported 75% of their patients received
permanent access following preoperative venography (with
iodine, CO2 or a combination of both or gadolinium), but
only half of them were AVFs.4
Although the number of suitable veins found on venog-
raphy was comparable to the study of Hyland et al.4 (1.7
veins per venogram vs. 1.9 veins per venogram), there were
some differences in the vein type. The percentage of
suitable basilic veins was higher both in the forearm and
the upper arm (23% and 84%, respectively). However, this
did not interfere substantially with the type of AVF that was
created, since the incidence of brachiobasilic AVFs created
(25%) was in the range of other studies (13e39%).11,12
Twenty percent of the AVFs in our series were radiocephalic
AVFs, which correlated well with the results of Patel et al.
and Huber et al. both of whom reported that 22% of their
procedures performed were radiocephalic AVF.11,12
Figure 1 Primary patency of the matured AVF.
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radiocephalic AVFs created (33%), but these were per-
formed in patients without prior permanent access of whom
25% were already considered suitable for native AVF based
on physical examination alone.13 The fact that in our study
as well as that of Hyland et al.,4 usable veins were not
identified by physical examination alone and that we
encountered 26% of patients with prior AVF in our study
might explain this difference. In all but two patients with
prior arteriovenous access, at least one prior access was
a radiocephalic AVF, reducing the possibility forming
a radiocephalic AVF. The incidence of brachiocephalic AVF
performed after preoperative imaging (33%) was also
comparable to other studies, in which brachiocephalic AVF
were created in approximately 35% of the patients.11,12
The prevalence of central venous stenosis/occlusion
precluding access creation in this study (7%) was in the
range of other studies of Hyland et al. (10%) and Huber
et al. (8%).4,12
The site of access surgery was at the surgeon’s discre-
tion, based on clinical examination and CO2 venography.
Correlation between CO2 venography findings and subse-
quent access surgery was high (90%), while Patel et al.
reported a correlation of 98% between the preoperatively
planned access and the actual procedure, using both US and
venography.11 In two patients, an AVF was created at the
elbow (one brachiocephalic and one brachialemedian vein
AVF) while CO2 venography demonstrated a patent cephalic
vein in the forearm in elderly patients where early dialysisFigure 2 Assisted primary patency of the matured AVF.was required. The higher maturation rate of brachioce-
phalic AVF over radiocephalic AVF in the series of Ngyen
et al. and Miller et al. would favour this approach in this
subset of patients in whom preservation of the veins as
much as possible may not be the main issue given their
age.14,15 However, this remains controversial as a study of
Weale et al. showed that age did not affect usability or
patency of either radiocephalic or brachiocephalic AVFs.16
In general, non-maturation or primary failure of the AVF
was seen in 17%, comparable to the study of Huber et al.
and Snyder et al. where an AVF maturation rate of 84% was
found,12,17 and slightly higher to the results of Elsharawy
et al. who reported early failure in 8% of patients who have
had access creation following preoperative venography.2
Allon et al. showed an overall primary access failure of 46%
for AVF in his series of access placement after sonographic
mapping.3 Patel et al. compared native fistulas created
after preoperative duplex US and venography with access
fistulas that were created before the liberal use of preop-
erative venous mapping and found that despite the increase
in native fistula creation, functional maturation rate
decreased from 73% to 57%.11 They reported that an AVF
created on the basis of vein identification at duplex US was
inferior to one created based on a vein that was identified
at physical examination only,11 suggesting that the quality
of the vein identified solely by vascular mapping might be
inferior to the quality of a vein that could be adequately
evaluated at physical examination (in a non-obese patient).
Maturation rates between patients with a prior AVF and
patients with a first-access AVF were not significantly
different and were higher than the 64% primary success
rate in the study of Wang et al. who reviewed the outcome
of AVF as first vascular access without preoperative
vascular mapping.18
The primary patency rates were comparable to other
studies on vascular mapping, where 1-year primary patency
ranged between 44% and 84% for AVF created after preop-
erative US.17,19 The percentage of forearm AVF was higher
in these studies (between 25% and 85% vs. 20%), but in the
majority of these studies preoperative mapping was done
routinely in all patients and not selectively in those
patients who were considered to have no suitable veins on
physical examination. Even though Kidney Disease Outcome
Quality Initiative (KDOQI) guidelines suggests vascular
mapping in every patient,6 this may not be necessary in
patients with favourable physical examination findings.20,21Figure 3 Secondary patency of the matured AVF.
Preoperative CO2 Venography 345Patel et al. noted that including patients with excellent
veins on physical examination in a routine preoperative
vein mapping protocol with duplex US would artificially
increase the results.11
The main limitation of this study is the fact that it was
a single centre, retrospective study with a relatively small
number of patients included.
In conclusion, CO2 venography is a useful tool for venous
mapping prior to vascular access surgery, resulting in an
overall maturation rate of 84% and patency rates compa-
rable to other studies on AVF creation after preoperative
vascular US.
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